• Amneal to acquire substantially all of Kashiv Specialty Pharmaceuticals pharmaceutical-business-review
    January 15, 2021
    Amneal Pharmaceuticals and Kashiv BioSciences announced they have entered into a definitive agreement under which Amneal Pharmaceuticals LLC, a wholly-owned subsidiary of the Company, will acquire a 98% interest in Kashiv Specialty Pharmaceuticals ...
PharmaSources Customer Service